You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

selumetinib

Showing 26 - 50 of 109
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Biliary Tract Carcinoma, Gallbladder Carcinoma Trial in Toronto (Selumetinib, Cisplatin, Gemcitabine)

Active, not recruiting
  • Biliary Tract Carcinoma
  • Gallbladder Carcinoma
  • Selumetinib
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 14, 2021

Neurofibromatosis 1, Neurofibromatosis Type 1, NF1 Trial run by the National Cancer Institute (NCI) (AZD6244)

Active, not recruiting
  • Neurofibromatosis 1
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Non-Metastatic Adenocarcinoma of the Rectum Trial run by the NCI (Radiation Therapy, Capecitabine, AZD6244)

Terminated
Has Results
  • Non-Metastatic Adenocarcinoma of the Rectum
  • Radiation Therapy
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 1, 2021

Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib 75 mg, Docetaxel 75

Completed
Has Results
  • Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
  • Selumetinib 75 mg
  • +3 more
  • Santa Monica, California
  • +50 more
Nov 22, 2022

KRAS NP_004976.2:p.G12R, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7 Trial in United

Completed
Has Results
  • KRAS NP_004976.2:p.G12R
  • +2 more
  • Laboratory Biomarker Analysis
  • Selumetinib Sulfate
  • Los Angeles, California
  • +8 more
Jan 20, 2021

NSCLC Trial in Canada (Selumetinib, Pemetrexed, Cisplatin)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Selumetinib
  • +3 more
  • Calgary, Alberta, Canada
  • +11 more
May 28, 2021

Low Grade Glioma, Neurofibromatosis Type 1, Visual Pathway Glioma Trial in Canada, Puerto Rico, United States (Carboplatin,

Recruiting
  • Low Grade Glioma
  • +2 more
  • Birmingham, Alabama
  • +120 more
Jan 27, 2023

Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Locally Advanced Malignant Solid Neoplasm
  • (no location specified)
Dec 2, 2022

Metastatic Pancreatic Adenocarcinoma Trial in France (Arm A - Olaparib, ARM B - durvalumab plus selumetinib, ARM C FOLFIRI)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Arm A - Olaparib
  • +2 more
  • Avignon, France
  • +28 more
Dec 29, 2020

Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib, Docetaxel, Placebo)

Active, not recruiting
Has Results
  • Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
  • Selumetinib
  • +3 more
  • Aurora, Colorado
  • +196 more
Dec 22, 2022

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in San Francisco, Columbus

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +3 more
  • erlotinib hydrochloride
  • +2 more
  • San Francisco, California
  • +1 more
Jul 29, 2020

NF type1 With Inoperable Plexiform Neurofibromas Trial in New Orleans (Selumetinib)

Approved for marketing
  • NF type1 With Inoperable Plexiform Neurofibromas
  • Selumetinib
  • New Orleans, Louisiana
    Research Site
Apr 30, 2020

Breast Cancer Trial in Houston (Dasatinib, AZD6244)

Terminated
Has Results
  • Breast Cancer
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

Borderline Ovarian Serous Tumor, Low Grade Ovarian Serous Adenocarcinoma, Micropapillary Serous Carcinoma Trial in United States

Completed
Has Results
  • Borderline Ovarian Serous Tumor
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Los Angeles, California
  • +48 more
Dec 2, 2020

Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)

Active, not recruiting
  • Muscle Invasive Bladder Cancer
  • Los Angeles, California
  • +26 more
Oct 17, 2022

Disfigurement From Photographs of Neurofibromatosis Type 1

Completed
  • Neurofibromatosis 1
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Non Small Cell Lung Cancer Trial in Canada (Paclitaxel, Carboplatin, Selumetinib)

    Completed
    • Non Small Cell Lung Cancer
    • Vancouver, British Columbia, Canada
    • +3 more
    Apr 6, 2020

    NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)

    Active, not recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Avignon, France
    • +36 more
    Jul 29, 2022

    Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Angers, France
    • +24 more
    Mar 8, 2022

    Lung Cancer, Melanoma, Head and Neck Carcinoma Trial in United States (Selumetinib, MEDI4736, Tremelimumab)

    Completed
    • Lung Cancer
    • +7 more
    • Selumetinib
    • +2 more
    • Chicago, Illinois
    • +5 more
    Nov 15, 2019

    NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Duarte, California
    • +52 more
    Jan 19, 2023

    NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)

    Active, not recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • Aberdeen, United Kingdom
    • +24 more
    Nov 2, 2021

    Gastric Adenocarcinoma Trial in Seoul (docetaxel plus selumetinib)

    Completed
    • Gastric Adenocarcinoma
    • docetaxel plus selumetinib
    • Seoul, Korea, Republic of
      Samsung Medical center
    May 17, 2019

    Tumors, Nerve Tissue, Neurofibromatosis 1, Heredodegenerative Disorders, Nervous System Trial (Selumetinib (AZD6244 hyd sulfate)

    Withdrawn
    • Neoplasms, Nerve Tissue
    • +3 more
    • Selumetinib (AZD6244 hyd sulfate) 50mg/dose
    • Selumetinib (AZD6244 hyd sulfate) 25mg/m2
    • (no location specified)
    Apr 3, 2019

    Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV) Trial in United States (Gefitinib, AZD9291,

    Completed
    Has Results
    • Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)
    • Goodyear, Arizona
    • +9 more
    Aug 1, 2019